Healthpeak Properties, Inc. (DOC)
NYSE: DOC · IEX Real-Time Price · USD
19.53
+0.06 (0.31%)
At close: Jul 2, 2024, 4:00 PM
19.10
-0.43 (-2.20%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for DOC stock have an average target of 19.25, with a low estimate of 14 and a high estimate of 25. The average target predicts a decrease of -1.43% from the current stock price of 19.53.
Analyst Consensus: Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for DOC stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 4 | 3 |
| Hold | 6 | 6 | 6 | 5 | 6 | 6 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 10 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $22 → $23 | Buy | Maintains | $22 → $23 | +17.77% | May 16, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $19 → $21 | Hold | Maintains | $19 → $21 | +7.53% | May 16, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | May 3, 2024 |
| Mizuho | Mizuho | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +12.65% | Apr 22, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +12.65% | Apr 10, 2024 |
Financial Forecast
Revenue This Year
2.64B
from 2.18B
Increased by 21.05%
Revenue Next Year
2.53B
from 2.64B
Decreased by -4.36%
EPS This Year
0.35
from 0.56
Decreased by -37.39%
EPS Next Year
0.39
from 0.35
Increased by 10.43%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.0B | 3.3B | 3.0B | 3.5B |
| Avg | 2.5B | 2.7B | 2.8B | 3.3B |
| Low | 2.1B | 2.2B | 2.6B | 3.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 37.2% | 30.9% | 13.0% | 23.3% |
| Avg | 15.8% | 6.2% | 4.4% | 18.6% |
| Low | -2.0% | -13.8% | -2.9% | 15.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.49 | 0.83 | 0.70 | 0.33 | 0.36 |
| Avg | 0.39 | 0.55 | 0.47 | 0.31 | 0.34 |
| Low | 0.18 | 0.24 | 0.25 | 0.30 | 0.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -11.9% | 114.3% | 27.0% | -30.7% | 14.0% |
| Avg | -30.9% | 43.0% | -15.2% | -33.3% | 9.7% |
| Low | -68.5% | -39.3% | -54.0% | -35.3% | 6.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.